SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
February 8, 2026
 · 
4 min read
Press Releases
Late-breaking data presentations showcase the safety and efficacy of Abbott’s ablation catheters to treat people with atrial fibrillation
February 8, 2026
 · 
5 min read
Press Releases
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
February 8, 2026
 · 
5 min read
Press Releases
Marriott foundations give $100 million to Mayo Clinic for healthcare transformation
February 8, 2026
 · 
4 min read
Press Releases
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 8, 2026
 · 
1 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 8, 2026
 · 
1 min read
Press Releases
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 8, 2026
 · 
1 min read
Press Releases
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 8, 2026
 · 
15 min read
Press Releases
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 8, 2026
 · 
1 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
 · 
7 min read
Press Releases
Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025
February 8, 2026
 · 
20 min read
Press Releases
Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)
February 8, 2026
 · 
6 min read
Press Releases
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
February 8, 2026
 · 
12 min read
Press Releases
Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
February 8, 2026
 · 
7 min read
Press Releases
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
February 8, 2026
 · 
7 min read
Press Releases
TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel
Key Commercialization Milestone in Retail Pharmacy Network that Serves Over 2.8 Million Insured Members
February 6, 2026
 · 
5 min read
Press Releases
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
Live Production Marketplace Now Available
February 6, 2026
 · 
5 min read
Press Releases
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
February 6, 2026
 · 
3 min read
Press Releases
NK Cell Therapeutics Autologous vs. Allogeneic: Who Will Lead the Race to Commercialization? - Commentary by Unexakorea
February 6, 2026
 · 
1 min read
Press Releases
Invitation to the Presentation of Cantargia’s Annual Results for 2025
February 6, 2026
 · 
1 min read
Press Releases
Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer
February 6, 2026
 · 
6 min read
Press Releases
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting
February 6, 2026
 · 
3 min read
Press Releases
HUTCHMED to Announce 2025 Final Results
February 6, 2026
 · 
1 min read
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
 · 
2 min read
Press Releases
Coloplast A/S - Interim Financial Report, Q1 2025/26
February 6, 2026
 · 
6 min read
Press Releases
Clear route to registration positions lucerastat as the potential first oral therapy for all patients with Fabry disease
February 6, 2026
 · 
12 min read
Press Releases
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
February 6, 2026
 · 
5 min read
Press Releases
Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer
February 6, 2026
 · 
4 min read
Press Releases
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
February 6, 2026
 · 
7 min read
Press Releases
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for ‘CART BP pro’ in Japan
February 6, 2026
 · 
4 min read
Press Releases
Aptar Reports Fourth Quarter and Annual 2025 Results
February 6, 2026
 · 
20 min read
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
 · 
3 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
 · 
4 min read
Load More